Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients ; volume:22 ; number:1 ; day:8 ; month:2 ; year:2024 ; pages:1-4 ; date:12.2024
BMC medicine ; 22, Heft 1 (8.2.2024), 1-4, 12.2024
- Urheber
-
Chatanaka, Miyo K.
Prassas, Ioannis
Diamandis, Eleftherios P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-024-03270-w
- URN
-
urn:nbn:de:101:1-2404170734192.170981896795
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chatanaka, Miyo K.
- Prassas, Ioannis
- Diamandis, Eleftherios P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease
Current state of Alzheimer’s fluid biomarkers
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease
Current state of Alzheimer’s fluid biomarkers
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease
Current state of Alzheimer’s fluid biomarkers